
Nimble Science
Home | Nimble Science | small intestine sampling technology
Calgary, Canada · Founded 2018 · $2.0M raised
- Headquarters
- Calgary
- Founded
- 2018
- Business Model
- B2B
- Website
- nimblesci.com
- Total Funding
- $2.0M
- Last Round
- $2.0M SeedFeb 2023
- Rounds
- 1
About
Nimble Science is a Calgary-based health technology company developing the SIMBA Capsule, an ingestible device that passively samples the small intestine to generate multi-omic microbiome and metabolite data that stool-based testing cannot capture. Co-founded by CEO Dr. Sabina Bruehlmann and CTO Dr. Joseph (Gang) Wang, the company partners with biopharma and nutrition companies to accelerate GI-focused drug and product development, and it received a Health Canada Class II license for the SIMBA Capsule and was named NutraIngredients-USA's 2024 Start-Up of the Year.
Summary
Nimble Science is a Biotech company based in Calgary, Canada, founded in 2018. It has raised $2.0M in total across 1 round, most recently a $2.0M Seed round in Feb 2023. Investors include Fusion Fund, First Spark Ventures and Alumni Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2023
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company

Specialty pharmaceutical company
